Iterion Therapeutic

BiPER Therapeutics

This company develops small molecule drugs targeting the BiP protein to treat gastrointestinal cancers and other pathological conditions in humans.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Peloton Therapeutics

This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.

Apexian Pharmaceuticals

This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Carrick Therapeutics

This biopharmaceutical company develops precision oncology therapies for patients with aggressive cancers, focusing on small molecules and inhibitors for solid tumours.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.